2024
Current Understanding of Compulsive Sexual Behavior Disorder and Co-occurring Conditions: What Clinicians Should Know about Pharmacological Options
Mestre-Bach G, Potenza M. Current Understanding of Compulsive Sexual Behavior Disorder and Co-occurring Conditions: What Clinicians Should Know about Pharmacological Options. CNS Drugs 2024, 38: 255-265. PMID: 38485889, DOI: 10.1007/s40263-024-01075-2.Peer-Reviewed Original ResearchConceptsCompulsive sexual behavior disorderSexual behavior disorderReuptake inhibitorsBehavioral disordersPornography usePharmacological treatmentCo-occurring disordersEmpirical supportSerotonin reuptake inhibitorsCo-occurring conditionsMood stabilizersPsychiatric disordersPsychological therapiesTricyclic antidepressantsGeneralizability of resultsOpioid antagonistSerotonin antagonistsDisordersSerotoninPharmacological optionsPharmacological approachesAntagonistPharmacological therapyNarrative reviewNefazodone
1998
Serotonin Transporter-Blocking Properties of Nefazodone Assessed by Measurement of Platelet Serotonin
Narayan M, Anderson G, Cellar J, Mallison R, Price L, Nelson J. Serotonin Transporter-Blocking Properties of Nefazodone Assessed by Measurement of Platelet Serotonin. Journal Of Clinical Psychopharmacology 1998, 18: 67-71.. PMID: 9472845, DOI: 10.1097/00004714-199802000-00011.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAntidepressive Agents, Second-GenerationBlood PlateletsCarrier ProteinsDepressive DisorderFemaleHumansMaleMembrane GlycoproteinsMembrane Transport ProteinsMiddle AgedNerve Tissue ProteinsPiperazinesSelective Serotonin Reuptake InhibitorsSerotoninSerotonin Plasma Membrane Transport ProteinsTriazolesConceptsSelective serotonin reuptake inhibitorsSerotonin reuptake inhibitorsHAM-D scoresHamilton Rating ScaleSerotonin type 2Nefazodone treatmentPretreatment plateletBaseline plateletSSRI treatmentReuptake inhibitorsUptake blockadeTherapeutic dosesPlatelet serotoninClinical dosesDepressed patientsMajor depressionTreatment groupsDepression scoresNefazodoneType 2Percent changeUptake inhibitionRating ScalePercent decreasePlatelets
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply